Ekto-5'-nukleotidaza (5'-ribonukleotidna fosfohidrolaza; EC 3.1.3.5) katalizuje konverziju na neutralnom pH purin 5' mononukleotida u nukleozide, pri čemu je preferentni supstrat AMP. Enzim se sastoji od dimera sa dve identične 70-kD podjedinice vezane glikozil fosfatidil inozitol vezom za spoljašnju stranu membrane plazme. Ovaj enzim se koristi kao marker diferencijacije limfocita. Konsekventno, deficijencija NT5 se javlja kod raznih bolesti imunodeficijencije (e.g., see MIM 102700, MIM 300300). Postoje druge forme 5' nukleotidaze u citoplazmi i lizozomima. One se razlikuju od ekto-NT5 po njihovim supstratnim afinitetima, potrebom za prisustvom divalentnog jona magnezijuma, ATP aktivaciji, i inhibiciji neorganskim fosfatima.[2] Retke alelne varijante su vezane za sindrom odraslog-doba kalcifikacije zglobova i arterija (CALJA) koji utiče na bočne, femoralnu, i tibijalne arterije čime se redukuje cirkulacija u nogama, i zglobovima ruku i stopala, što uzrokuje bol.[3][4][5]
^Misumi Y, Ogata S, Ohkubo K, Hirose S, Ikehara Y (1990). „Primary structure of human placental 5'-nucleotidase and identification of the glycolipid anchor in the mature form”. Eur. J. Biochem. 191 (3): 563—9. PMID2129526. doi:10.1111/j.1432-1033.1990.tb19158.x.
Kirchhoff C, Hale G (1997). „Cell-to-cell transfer of glycosylphosphatidylinositol-anchored membrane proteins during sperm maturation.”. Mol. Hum. Reprod. 2 (3): 177—84. PMID9238677. doi:10.1093/molehr/2.3.177.
Rosi F, Carlucci F, Marinello E, Tabucchi A (2002). „Ecto-5'-nucleotidase in B-cell chronic lymphocytic leukemia.”. Biomed. Pharmacother. 56 (2): 100—4. PMID12000134. doi:10.1016/S0753-3322(01)00072-5.
Babiychuk EB, Draeger A (2006). „Regulation of ecto-5'-nucleotidase activity via Ca2+-dependent, annexin 2-mediated membrane rearrangement?”. Biochem. Soc. Trans. 34 (Pt 3): 374—6. PMID16709165. doi:10.1042/BST0340374.
Stefanovic V, Mandel P, Rosenberg A (1976). „Ecto-5'-nucleotidase of intact cultured C6 rat glioma cells.”. J. Biol. Chem. 251 (13): 3900—5. PMID819433.
Thomson LF, Ruedi JM, Glass A, et al. (1990). „Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5'-nucleotidase (CD73).”. Tissue Antigens. 35 (1): 9—19. PMID2137649. doi:10.1111/j.1399-0039.1990.tb01750.x.
Klemens MR, Sherman WR, Holmberg NJ, et al. (1990). „Characterization of soluble vs membrane-bound human placental 5'-nucleotidase.”. Biochem. Biophys. Res. Commun. 172 (3): 1371—7. PMID2173922. doi:10.1016/0006-291X(90)91601-N.
Boyle JM, Hey Y, Guerts van Kessel A, Fox M (1989). „Assignment of ecto-5'-nucleotidase to human chromosome 6.”. Hum. Genet. 81 (1): 88—92. PMID2848759. doi:10.1007/BF00283737.
Vlahović P, Stefanović V (1995). „Effect of dopamine on ecto-5'-nucleotidase expression in human glomerular mesangial cells.”. Archives internationales de physiologie, de biochimie et de biophysique. 102 (3): 171—3. PMID8000038.
Hansen KR, Resta R, Webb CF, Thompson LF (1996). „Isolation and characterization of the promoter of the human 5'-nucleotidase (CD73)-encoding gene.”. Gene. 167 (1-2): 307—12. PMID8566797. doi:10.1016/0378-1119(95)00574-9.
Airas L, Jalkanen S (1996). „CD73 mediates adhesion of B cells to follicular dendritic cells.”. Blood. 88 (5): 1755—64. PMID8781432.
Aumüller G, Renneberg H, Schiemann PJ, et al. (1998). „The role of apocrine released proteins in the post-testicular regulation of human sperm function.”. Adv. Exp. Med. Biol. 424: 193—219. PMID9361795. doi:10.1007/978-1-4615-5913-9_39.
Rosi F, Agostinho AB, Carlucci F, et al. (1998). „Behaviour of human lymphocytic isoenzymes of 5'-nucleotidase.”. Life Sci. 62 (25): 2257—66. PMID9651114. doi:10.1016/S0024-3205(98)00206-9.
. PMID 21288095. doi:10.1056/NEJMoa0912923.
